About Traverse Heart and Vascular
Clinical Trials at Traverse Heart and Vascular
During the past decade, Traverse Heart and Vascular conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Traverse Heart and Vascular"
#1 collaborator was "University of Rochester" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Traverse Heart and Vascular
According to Clinical.Site data, the most researched conditions in "Traverse Heart and Vascular" are
"Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiomyopathies" (1 trials), "Gender" (1 trials) and "Implantable Defibrillator User" (1 trials). Many other conditions were trialed in "Traverse Heart and Vascular" in a lesser frequency.
Clinical Trials Intervention Types at Traverse Heart and Vascular
Most popular intervention types in "Traverse Heart and Vascular" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Inclisiran sodium 300 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Traverse Heart and Vascular
The vast majority of trials in "Traverse Heart and Vascular" are
2 trials for "All" genders.
Clinical Trials Status at Traverse Heart and Vascular
Currently, there are NaN active trials in "Traverse Heart and Vascular".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Traverse Heart and Vascular,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Traverse Heart and Vascular, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".